187 related articles for article (PubMed ID: 24097974)
1. Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.
Peng M; Zhang H; Jaafar L; Risinger JI; Huang S; Mivechi NF; Ko L
J Biol Chem; 2013 Nov; 288(46):33387-97. PubMed ID: 24097974
[TBL] [Abstract][Full Text] [Related]
2. GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.
Yang Z; Peng M; Cheng L; Jones K; Maihle NJ; Mivechi NF; Ko L
Am J Pathol; 2016 May; 186(5):1340-50. PubMed ID: 27001628
[TBL] [Abstract][Full Text] [Related]
3. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.
Peng M; Bakker JL; Dicioccio RA; Gille JJ; Zhao H; Odunsi K; Sucheston L; Jaafar L; Mivechi NF; Waisfisz Q; Ko L
Genes Cancer; 2013 Jan; 4(1-2):15-25. PubMed ID: 23946868
[TBL] [Abstract][Full Text] [Related]
4. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
[TBL] [Abstract][Full Text] [Related]
5. The orphan nuclear receptor NR4A1 regulates transcription of key steroidogenic enzymes in ovarian theca cells.
Li M; Xue K; Ling J; Diao FY; Cui YG; Liu JY
Mol Cell Endocrinol; 2010 May; 319(1-2):39-46. PubMed ID: 20083153
[TBL] [Abstract][Full Text] [Related]
6. GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating Mutations.
Peng M; Yang Z; Zhang H; Jaafar L; Wang G; Liu M; Flores-Rozas H; Xu J; Mivechi NF; Ko L
Genes Cancer; 2013 Jan; 4(1-2):26-38. PubMed ID: 23946869
[TBL] [Abstract][Full Text] [Related]
7. Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.
Wickenheisser JK; Nelson-DeGrave VL; Quinn PG; McAllister JM
Mol Endocrinol; 2004 Mar; 18(3):588-605. PubMed ID: 14684846
[TBL] [Abstract][Full Text] [Related]
8. Paracrine regulation of theca androgen production by granulosa cells in the ovary.
Hoang YD; McTavish KJ; Chang RJ; Shimasaki S
Fertil Steril; 2013 Aug; 100(2):561-7. PubMed ID: 23706336
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: a potential mechanism in ovarian tumorigenesis.
Blanco LZ; Kuhn E; Morrison JC; Bahadirli-Talbott A; Smith-Sehdev A; Kurman RJ
Mod Pathol; 2017 Apr; 30(4):563-576. PubMed ID: 28059101
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and biochemical analysis of a human Sertoli-Leydig cell tumor: autonomous steroid production characteristic of ovarian theca cells.
Sawetawan C; Rainey WE; Word RA; Carr BR
J Soc Gynecol Investig; 1995; 2(1):30-7. PubMed ID: 9420846
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-Degrave VL; McAllister JM
J Clin Endocrinol Metab; 2005 Mar; 90(3):1720-7. PubMed ID: 15598676
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone (LH) regulates production of androstenedione and progesterone via control of histone acetylation of StAR and CYP17 promoters in ovarian theca cells.
Murayama C; Miyazaki H; Miyamoto A; Shimizu T
Mol Cell Endocrinol; 2012 Mar; 350(1):1-9. PubMed ID: 22155568
[TBL] [Abstract][Full Text] [Related]
13. The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model.
Beshay VE; Havelock JC; Sirianni R; Ye P; Suzuki T; Rainey WE; Carr BR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4802-9. PubMed ID: 17895316
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism for repression of 17alpha-hydroxylase expression and androstenedione production in granulosa cells.
Patel SS; Beshay VE; Escobar JC; Suzuki T; Carr BR
J Clin Endocrinol Metab; 2009 Dec; 94(12):5163-8. PubMed ID: 19850690
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.
Ko L; Cardona GR; Henrion-Caude A; Chin WW
Mol Cell Biol; 2002 Jan; 22(1):357-69. PubMed ID: 11739747
[TBL] [Abstract][Full Text] [Related]
16. Effect of the spatial-temporal specific theca cell Cyp17 overexpression on the reproductive phenotype of the novel TC17 mouse.
Secchi C; Belli M; Harrison TNH; Swift J; Ko C; Duleba AJ; Stupack D; Chang RJ; Shimasaki S
J Transl Med; 2021 Oct; 19(1):428. PubMed ID: 34654452
[TBL] [Abstract][Full Text] [Related]
17. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells.
Zhang G; Garmey JC; Veldhuis JD
Endocrinology; 2000 Aug; 141(8):2735-42. PubMed ID: 10919257
[TBL] [Abstract][Full Text] [Related]
18. Steroid localization in granulosa-theca tumors of the ovary.
Kurman RJ; Goebelsmann U; Taylor CR
Cancer; 1979 Jun; 43(6):2377-84. PubMed ID: 378357
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein inhibits ovarian androgen production.
Dooley CA; Attia GR; Rainey WE; Moore DR; Carr BR
J Clin Endocrinol Metab; 2000 Sep; 85(9):3331-7. PubMed ID: 10999829
[TBL] [Abstract][Full Text] [Related]
20. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
Nelson-Degrave VL; Wickenheisser JK; Hendricks KL; Asano T; Fujishiro M; Legro RS; Kimball SR; Strauss JF; McAllister JM
Mol Endocrinol; 2005 Feb; 19(2):379-90. PubMed ID: 15514033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
